BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 4627946)

  • 1. A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement.
    Dormont J; Kreis H; Leski M; Bach JF; Crosnier J
    Rev Eur Etud Clin Biol; 1972 Apr; 17(4):382-9. PubMed ID: 4627946
    [No Abstract]   [Full Text] [Related]  

  • 2. Causes of allograft failure in recipients treated with and without antilymphocyte globulin.
    Sheil AG; May J; Rogers JH; Storey BG; Katran DC; Duggin GG; Johnson JR; Stewart JH
    Transplant Proc; 1973 Mar; 5(1):561-5. PubMed ID: 4121179
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antilymphocytic globulin (GAL). Clinical use in 18 renal transplantation patients].
    Galvão MM; Mendes NF; Ramos OL; Sabbaga E
    Rev Bras Pesqui Med Biol; 1972; 5(5):251-8. PubMed ID: 4573042
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical evaluation of the immunogenicity of horse and rabbit antihuman lymphocyte globulin in renal transplantation.
    Cerilli GJ; Miller A; Hattan D
    Surg Forum; 1970; 21():250-2. PubMed ID: 4936976
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical use of rabbit antihuman lymphocyte globulin in cadaver-kidney transplantation.
    Mannick JA; Davis RC; Cooperband SR; Glasgow AH; Williams LF; Harrington JT; Cavallo T; Schmitt GW; Idelson BA; Olsson CA; Nabseth DC
    N Engl J Med; 1971 May; 284(20):1109-15. PubMed ID: 4928659
    [No Abstract]   [Full Text] [Related]  

  • 6. Canadian clinical trial of antilymphocyte globulin in human cadaver renal transplantation.
    Taylor HE; Ackman CF; Horowitz I
    Can Med Assoc J; 1976 Dec; 115(12):1205-8. PubMed ID: 793705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis and management of rejection in allografted kidneys.
    Merrill JP
    Transplant Proc; 1971 Mar; 3(1):287-92. PubMed ID: 4937895
    [No Abstract]   [Full Text] [Related]  

  • 8. Failure of 125I-tracer selective monoclonal antibody levels on a whole blood matrix to predict rejection or nephrotoxic episodes in renal transplant patients under anti-lymphocyte globulin and prednisone therapy.
    Stiller C; Keown P
    Transplant Proc; 1990 Jun; 22(3):1253-4. PubMed ID: 2349687
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical renal transplantation.
    Kountz SL
    Transplant Proc; 1974 Dec; 6(4 Suppl 1):99-105. PubMed ID: 4612909
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled trial antilymphocyte globulin therapy (ALG) in man.
    Sheil AG; Mears D; Kelly GE; Stewart JH; Johnson JR; Tiller D; Gallery ED; Duggin GG
    Transplant Proc; 1972 Dec; 4(4):501-5. PubMed ID: 4118965
    [No Abstract]   [Full Text] [Related]  

  • 11. Prednisone used as treatment for rejection correlates with poor outcome.
    Toussaint RM; Callender CO; Dunston GM; Flores J; Walters CS; John D; Yeager C; Bond O; Thompson C; Gear JC
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1712-5. PubMed ID: 2652561
    [No Abstract]   [Full Text] [Related]  

  • 12. Improvement in cadaveric renal transplant survival.
    Beaudoin JG; Guttmann RD; Morehouse DD; Knaack J; Chassot PG
    Arch Surg; 1973 Aug; 107(2):245-9. PubMed ID: 4578273
    [No Abstract]   [Full Text] [Related]  

  • 13. Low-dose cyclosporine, anti-lymphocyte globulin, and steroids in first cadaveric renal transplantation.
    Griño JM; Alsina J; Castelao AM; Sabate I; Mestre M; Gil-Vernet S; Andrés E; Sabater R
    Transplant Proc; 1988 Oct; 20(5 Suppl 6):18-20. PubMed ID: 3051579
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression by antihuman lymphocyte globulin: correlation of human and animal assay systems with clinical results.
    Simmons RL; Moberg AW; Gewurz H; Soll R; Najarian JS
    Transplant Proc; 1971 Mar; 3(1):745-8. PubMed ID: 4999469
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of sensitization to horse antilymphocyte/thymocyte globulin with recipient age and decreased renal allograft survival rates.
    Filo RS; Book B; Pescovitz MD; Milgrom ML; Leapman SB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):577-80. PubMed ID: 8438421
    [No Abstract]   [Full Text] [Related]  

  • 16. Antilymphocyte induction immunosuppression in the post-Minnesota anti-lymphocyte globulin era: incidence of renal dysfunction and delayed graft function. A single center experience.
    Malinow L; Walker J; Klassen D; Oldach D; Schweitzer E; Bartlett ST; Weir MR
    Clin Transplant; 1996 Jun; 10(3):237-42. PubMed ID: 8826659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant immunosuppression in renal transplantation: high dose intravenous steroids, local radiation therapy, and antilymphocyte globulin.
    Turcotte JG; Freier DT; Dickerman R
    Urol Clin North Am; 1976 Oct; 3(3):597-610. PubMed ID: 790733
    [No Abstract]   [Full Text] [Related]  

  • 18. [Follow-ups after kidney transplantations].
    Halbfass HJ; Staib I; Heinze V; Jontofsohn R; Junkers K
    Dtsch Med Wochenschr; 1973 Mar; 98(10):479-81. PubMed ID: 4570868
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experience with antilymphocyte globulin (ALG) in renal transplantation.
    Deodhar SD; Konomi K; Nakamoto S; Kuruvila KC
    Transplant Proc; 1971 Mar; 3(1):758-61. PubMed ID: 4937968
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress in clinical organ transplantation.
    Monaco AP
    Surg Annu; 1971; 3(0):97-123. PubMed ID: 4950707
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.